Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Protagonist Therapeutics Inc have a median target of 50.50, with a high estimate of 60.00 and a low estimate of 43.00. The median estimate represents a 9.97% increase from the last price of 45.92.
High | 30.7% | 60.00 |
Med | 10.0% | 50.50 |
Low | -6.4% | 43.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | +327.81% |
Average growth rate | +11.45% |
More ▼
Revenue history & estimates in USD
Average growth rate | +75.52% |
Average growth rate | +3,102.88% |
More ▼